PHARMAGIVES: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMAGIVES
Largest movements
- Receivables within one year +€31,020
up €31,020 (+46.2%), from €67,189 to €98,209
of which Other amounts receivable: +€33,783
- Stocks and contracts +€8,706
up €8,706 (+9.8%), from €88,841 to €97,547
- Tangible fixed assets -€5,877
down €5,877 (-4.8%), from €122,116 to €116,239
of which Plant, machinery and equipment: -€22,597
- Intangible fixed assets +€4,092
new in 2025: €4,092
- Current portion of long-term debt +€22,692
up €22,692 (+52.0%), from €43,644 to €66,336
- Trade debts +€13,609
up €13,609 (+10.7%), from €127,027 to €140,637
- Debts after one year +€5,115
up €5,115 (+6.6%), from €77,188 to €82,302
of which Other amounts payable: +€10,000
- Other debts -€4,180
down €4,180 (-58.1%), from €7,201 to €3,021
- Staff costs +€10,446
up €10,446 (+10.3%), from €101,545 to €111,991
- Depreciation -€4,069
down €4,069 (-13.0%), from €31,183 to €27,114
- Other operating charges -€3,762
down €3,762 (-80.9%), from €4,652 to €890
- Gross operating margin +€3,224
up €3,224 (+2.2%), from €144,324 to €147,548
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €306,042 | €343,524 | +€37,482 | +12.2% |
| Fixed assets | 21/28 | €122,116 | €120,332 | -€1,784 | -1.5% |
| Intangible fixed assets | 21 | - | €4,092 | +€4,092 | |
| Tangible fixed assets | 22/27 | €122,116 | €116,239 | -€5,877 | -4.8% |
| Plant, machinery and equipment | 23 | €109,369 | €86,772 | -€22,597 | -20.7% |
| Furniture and vehicles | 24 | €12,747 | €29,468 | +€16,720 | +131% |
| Current assets | 29/58 | €183,926 | €223,193 | +€39,266 | +21.3% |
| Stocks and contracts in progress | 3 | €88,841 | €97,547 | +€8,706 | +9.8% |
| Stocks | 30/36 | €88,841 | €97,547 | +€8,706 | +9.8% |
| Amounts receivable within one year | 40/41 | €67,189 | €98,209 | +€31,020 | +46.2% |
| Trade receivables | 40 | €60,341 | €57,578 | -€2,763 | -4.6% |
| Other amounts receivable | 41 | €6,848 | €40,631 | +€33,783 | +493% |
| Cash at bank and in hand | 54/58 | €26,689 | €24,027 | -€2,662 | -10.0% |
| Deferred charges and accrued income | 490/1 | €1,208 | €3,411 | +€2,203 | +182% |
| Total equity and liabilities | 10/49 | €306,042 | €343,524 | +€37,482 | +12.2% |
| Equity | 10/15 | €3,985 | €3,709 | -€276 | -6.9% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €48,473 | €48,473 | = | 0.0% |
| Distributable reserves | 133 | €48,473 | €48,473 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€56,888 | -€57,164 | -€276 | -0.5% |
| Amounts payable | 17/49 | €302,057 | €339,816 | +€37,758 | +12.5% |
| Amounts payable after more than one year | 17 | €77,188 | €82,302 | +€5,115 | +6.6% |
| Financial debts | 170/4 | €77,188 | €72,302 | -€4,885 | -6.3% |
| Other amounts payable | 178/9 | - | €10,000 | +€10,000 | |
| Amounts payable within one year | 42/48 | €221,770 | €254,413 | +€32,644 | +14.7% |
| Current portion of amounts payable after more than one year | 42 | €43,644 | €66,336 | +€22,692 | +52.0% |
| Financial debts | 43 | €25,000 | €25,000 | = | 0.0% |
| Credit institutions | 430/8 | €25,000 | €25,000 | = | 0.0% |
| Trade debts | 44 | €127,027 | €140,637 | +€13,609 | +10.7% |
| Suppliers | 440/4 | €127,027 | €140,637 | +€13,609 | +10.7% |
| Taxes, remuneration and social security | 45 | €18,897 | €19,420 | +€523 | +2.8% |
| Taxes | 450/3 | €2,686 | €4,420 | +€1,734 | +64.6% |
| Remuneration and social security | 454/9 | €16,211 | €15,000 | -€1,211 | -7.5% |
| Other amounts payable | 47/48 | €7,201 | €3,021 | -€4,180 | -58.1% |
| Accrued charges and deferred income | 492/3 | €3,100 | €3,100 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €101,545 | €111,991 | +€10,446 | +10.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €31,183 | €27,114 | -€4,069 | -13.0% |
| Other operating charges | 640/8 | €4,652 | €890 | -€3,762 | -80.9% |
| Gross operating margin | 9900 | €144,324 | €147,548 | +€3,224 | +2.2% |
| Operating profit (loss) | 9901 | €6,944 | €7,553 | +€609 | +8.8% |
| Financial income | 75/76B | €15 | €41 | +€27 | +182% |
| Recurring financial income | 75 | €15 | €41 | +€27 | +182% |
| Financial charges | 65/66B | €6,085 | €6,329 | +€244 | +4.0% |
| Recurring financial charges | 65 | €6,085 | €6,329 | +€244 | +4.0% |
| Profit (loss) for the period before taxes | 9903 | €873 | €1,265 | +€391 | +44.8% |
| Income taxes | 67/77 | €1,172 | €1,541 | +€369 | +31.5% |
| Profit (loss) for the period | 9904 | -€298 | -€276 | +€22 | +7.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€298 | -€276 | +€22 | +7.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.